Neurosurgeon Elected to Prestigious National Academy of Medicine

On Oct. 17, the prestigious  National Academy of Medicine  announced  the election of another neurosurgeon to its ranks: James M. Markert, MD, MPH, FAANS, chair, department of neurosurgery, University of Alabama, Birmingham. He was recognized as a world expert on oncolytic viruses, an author of the first-ever paper on genetically engineered oncolytic viruses, the primary author on the first-in-human trial of an oncolytic virus and senior author on the first use of an IL12-expressing virus for human glioma. Dr. Markert is currently conducting adult and pediatric brain tumor trials.